Ricerca avanzata

Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 Marzo;49(1) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 Marzo;49(1):30-42

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 Marzo;49(1):30-42

NUCLEAR CARDIOLOGY: THE PRESENT AND THE FUTURE
Guest Editors: R. Sciagrà and J. J. Bax 

 REVIEW ARTICLES

Attenuation correction: eternal dilemma or real improvement?

Hendel R. C.

Midwest Heart Specialists, Fox River, IL, USA

SPECT myocardial perfusion imaging is a clinical standard for the care of cardiac patients. During the past 2 decades, this method has continued to evolve and significant improvements in image quality have been realized. Despite these continued improvements, imaging artifacts remain problematic and often confound accurate image interpretation. The most frequent and difficult cause of myocardial perfusion imaging artifacts continues to be related to soft tissue attenuation and resultant photon attenuation. Methods for non-uniform attenuation correction have progressed slowly until recently, but there are now a number of techniques, which offer true correction for photon attenuation. Clinical validation has demonstrated clear clinical benefits for this technology and the field of nuclear cardiology enthusiastically supports these technical advances. However, additional clinical validation is warranted especially for commercially available systems that have not yet been evaluated with rigor.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina